Experienced in Mycobacterium Avium Complex Infections

Casper Rokx

Erasmus MC
Rotterdam, ZH, NL 
Experienced in Mycobacterium Avium Complex Infections
Erasmus MC
Rotterdam, ZH, NL 
OverviewLocationsClinical Research

Overview

Casper Rokx practices in Rotterdam, Netherlands. Mr. Rokx is rated as an Experienced expert by MediFind in the treatment of Mycobacterium Avium Complex Infections. His top areas of expertise are HIV/AIDS, COVID-19, Cervical Dysplasia, and Severe Acute Respiratory Syndrome (SARS).

His clinical research consists of co-authoring 107 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Mycobacterium Avium Complex Infections.

Gender
Male

Locations

Erasmus MC
Rotterdam, ZH, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Convalescent Plasma Therapy From Recovered Covid-19 Patients as Therapy for Hospitalized Patients With Covid-19
Convalescent Plasma Therapy From Recovered Covid-19 Patients as Therapy for Hospitalized Patients With Covid-19
Enrollment Status: Terminated
Publish Date: April 01, 2022
Intervention Type: Biological
Study Drug: Convalescent Plasma
Study Phase: Phase 2/Phase 3
Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study)
Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study)
Enrollment Status: Terminated
Publish Date: April 01, 2022
Intervention Type: Biological
Study Drug: Anti-COVID-19 Plasma
Study Phase: Phase 3
View 1 Less Clinical Trial

107 Total Publications

Estimated 10-year risk of recurrent cardiovascular events and potential health benefits of secondary prevention in people with HIV.
Estimated 10-year risk of recurrent cardiovascular events and potential health benefits of secondary prevention in people with HIV.
Journal: AIDS (London, England)
Published: July 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Rokx's expertise for a condition
ConditionClose
    View All 12 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile